CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 87 enrolled
Drug / intervention
Delefilcon A Multifocal Contact Lenses with Molded Mark +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02939170
NCT02939170N/ACompleted
CompareCT.gov

Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks

Alcon, a Novartis Company·interventional·Posted Oct 19, 2016·Updated Jul 2, 2018

In Brief

A clinical study evaluating Delefilcon A Multifocal Contact Lenses with Molded Mark and Delefilcon A Multifocal Contact Lenses for Refractive Error. Completed, enrolled 87 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the impact of back surface molded marks (MM) applied to delefilcon A contact lenses as measured by the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® Multifocal contact lenses with molded marks (DT1 MF MM) and current DAILIES TOTAL1® Multifocal contact lenses (DT1 MF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Error
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 19, 2016
Enrollment StartNov 14, 2016
Primary CompletionDec 2, 2016
TodayJul 2, 2026
Enrollment to primary: 18 daysPosted 9.7 years ago

Interventions

Delefilcon A Multifocal Contact Lenses with Molded Markdevice

Delefilcon A Multifocal Contact Lensesdevice